Category: Pharmaceutical Claim
Urgent Product Information Bulletin: Takeda Pharmaceutical Co. has agreed to a $2.4 billion settlement to resolve bladder cancer claims resulting from Actos use. The settlement was designed to compensate claimants based upon the extent of their injuries and their cumulative exposure to Actos, taking into account risk factors…